Clinical Trial: CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
Study Status: Active, not recruiting
Recruit Status: Active, not recruiting
Condition: In-stent Restenosis
Study Type: Interventional
Official Title: Everolimus-Coated Percutaneous Transluminal Coronary Angioplasty Catheter First in Human Clinical Investigation: A Clinical Evaluation in the Treatment of Subjects With In-Stent Restenosis of Previous
Brief Summary:
The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.
Read more